Treatment of fascioliasis in human infections (multiple letters)

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue 2, 2006, Pages 187-188

  Coles, Gerald C ^a   Curtale, Filippo ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UO Malattie Infettive   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; TRICLABENDAZOLE;

DRUG CHOICE; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; FASCIOLA HEPATICA; FASCIOLIASIS; HUMAN; LETTER; NONHUMAN; PARASITE CONTROL; THERAPY RESISTANCE; TREATMENT FAILURE;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; DRUG RESISTANCE; FASCIOLIASIS; HUMANS;

FASCIOLA HEPATICA;

EID: 29744448676     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2005.08.002     Document Type: Letter

References (4)

1. G.C. Coles K.A. Stafford Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica Vet. Rec. 148 2001 723-724
2. G.C. Coles A.C. Rhodes K.A. Stafford The activity of closantel against adult triclabendazole-resistant Fasciola hepatica Vet. Rec. 146 2000 504
3. F. Curtale Y.A.E.W. Hassanein L. Savioli Control of human fascioliasis by selective chemotherapy: Design, cost and the effect of the first public health, school-based intervention implemented in endemic areas of the Nile Delta, Egypt Trans. R. Soc. Trop. Med. Hyg. 99 2005 599-609
4. R. Saba M. Korkmaz D. Inan L. Mamikoǧlu Ö. Turham F. Gunseren C. Cevikol A. Kabaalioǧlu Human fascioliasis Clin. Microbiol. Infect. 10 2004 385-387